サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1769616

ホルモン補充療法の世界市場レポート2025年

Hormone Replacement Therapy Global Market Report 2025

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.54円
ホルモン補充療法の世界市場レポート2025年
出版日: 2025年07月07日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ホルモン補充療法市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.6％で379億米ドルに成長します。予測期間中の成長は、ホルモン障害の有病率の増加、更年期の健康に対する意識の高まり、世界の高齢化人口の増加、新興市場における医療アクセスの拡大、低侵襲治療オプションに対する需要の高まりに起因すると考えられます。この時期の主要動向としては、バイオアイデンティカルホルモン製剤の進歩、先進的経皮ドラッグデリバリー技術、遺伝子プロファイリングによる個別化ホルモン療法の開発、長時間作用型ホルモン注射剤の革新、ホルモン療法管理のための遠隔医療統合の進展などが挙げられます。

閉経後女性の増加は、今後のホルモン補充療法市場の拡大を牽引すると予想されます。閉経後女性とは、生殖ホルモンの自然な減少により月経が永久に止まった女性のことで、通常は最後の月経から12ヵ月後に起こります。この閉経後女性の増加は、女性の長寿化による平均寿命の伸びと関連しており、閉経を迎える女性の高齢化人口の増加につながります。ホルモン補充療法は、ほてりや寝汗などの一般的な症状を和らげることで、閉経後の女性の生活の質を高めています。個別化された治療によりホルモンバランスを維持し、不快感を軽減し、全身の健康をサポートします。例えば、2022年7月、米国のヘルスケア機関であるメイヨークリニックヘルスシステムは、更年期と閉経後女性の世界人口は2030年までに12億人に達し、毎年4,700万人が新たに発症すると予測していると報告しました。その結果、閉経後女性の増加がホルモン補充療法市場の成長に拍車をかけています。

ホルモン補充療法市場の主要企業は、治療効果と患者のアドヒアランスを高めるため、バイオアイデンティカルホルモン製剤を含む革新的な製剤の開発に注力しています。バイオアイデンティカルホルモン製剤は、人体で自然に産生されるホルモンと化学的に同一のホルモンを利用するもので、より自然で効率的な症状緩和と副作用の軽減を目指しています。例えば、2024年5月、インドの製薬会社Jagsonpal Pharmaceuticals Ltd.は、バイオアイデンティカルHRTであるMemUpを発表しました。この先進的な治療は、エストラジオールとプロゲステロンを1日1回経口カプセルに配合したものです。メムアップは、ほてりや寝汗などの一般的な更年期症状を効果的に緩和するとともに、患者の利便性とコンプライアンスを向上させるために治療プロセスを簡素化するよう設計されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界のホルモン補充療法：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界のホルモン補充療法市場：成長率分析
  • 世界のホルモン補充療法市場の実績：規模と成長、2019～2024年
  • 世界のホルモン補充療法市場の予測：規模と成長、2024～2029年、2034年
  • 世界のホルモン補充療法：総潜在市場規模（TAM）

第6章 市場セグメンテーション

  • 世界のホルモン補充療法市場：治療タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • エストロゲン補充療法
  • ヒト成長ホルモン（hGH）補充療法
  • 甲状腺ホルモン補充療法
  • テストステロン補充療法
  • その他
  • 世界のホルモン補充療法市場：適応症別、実績と予測、2019～2024年、2024～2029年、2034年
  • 閉経
  • 甲状腺機能低下症
  • 男性性腺機能低下症
  • 成長ホルモン欠乏症
  • その他
  • 世界のホルモン補充療法市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
  • 経口
  • 経皮
  • 注射
  • その他の投与経路
  • 世界のホルモン補充療法市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他
  • 世界のホルモン補充療法市場、エストロゲン補充療法のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 経口エストロゲン
  • 経皮エストロゲン
  • 局所エストロゲン
  • 膣エストロゲン
  • 注射用エストロゲン
  • 世界のホルモン補充療法市場、ヒト成長ホルモン（hGH）補充療法のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • ソマトロピン
  • ソマトレム
  • 組み換えヒト成長ホルモン（rhGH）
  • ペグ化hGH
  • その他のヒト成長ホルモン（hGH）補充療法
  • 世界のホルモン補充療法市場、甲状腺ホルモン補充療法のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • レボチロキシン（T4）
  • リオチロニン（T3）
  • 天然乾燥甲状腺（NDT）
  • リオチロニン（T3）またはレボチロキシン（T4）の併用療法
  • 世界のホルモン補充療法市場、テストステロン補充療法のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • ジェルとクリーム
  • 注射
  • パッチ
  • 経口テストステロン
  • ペレット
  • 世界のホルモン補充療法市場、その他のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • プロゲステロン補充療法
  • エストロゲンプロゲステロン併用療法
  • デヒドロエピアンドロステロン療法
  • メラトニン補充療法

第7章 地域別・国別分析

  • 世界のホルモン補充療法市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
  • 世界のホルモン補充療法市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ホルモン補充療法市場：競合情勢
  • ホルモン補充療法市場：企業プロファイル
    • Pfizer Inc.
    • F. Hoffmann-La Roche Ltd.
    • AbbVie Inc.
    • Bayer AG
    • Sanofi S.A.

第31章 その他の大手企業と革新的企業

  • Abbott Laboratories
  • Novartis AG
  • GSK plc
  • Eli Lilly and Company
  • Amgen Inc.
  • Novo Nordisk A/S
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Bausch Health Companies Inc.
  • Cipla Inc.
  • Gedeon Richter Plc.
  • Lupin Limited
  • Orion Corporation
  • Halozyme Therapeutics Inc.
  • Theramex HQ UK Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

  • ホルモン補充療法市場、2029年：新たな機会を提供する国
  • ホルモン補充療法市場、2029年：新たな機会を提供するセグメント
  • ホルモン補充療法市場、2029年：成長戦略
    • 市場動向による戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r35931

Hormone replacement therapy (HRT) is a medical procedure that provides the body with hormones that it no longer produces in adequate amounts. It is primarily used to ease symptoms linked to menopause, including hot flashes, night sweats, mood changes, and more.

The main types of hormone replacement therapy consist of estrogen replacement therapy, human growth hormone replacement therapy, thyroid hormone replacement therapy, testosterone replacement therapy, and others. Estrogen replacement therapy involves supplementing estrogen hormones to reduce symptoms caused by estrogen deficiency, such as those experienced during menopause. This therapy is applied for various conditions like menopause, hypothyroidism, male hypogonadism, growth hormone deficiency, among others, and can be administered orally, through the skin, by injection, and other methods. The primary distribution channels include hospital pharmacies, retail pharmacies, online pharmacies, and others.

The hormone replacement therapy market research report is one of a series of new reports from The Business Research Company that provides hormone replacement therapy market statistics, including the hormone replacement therapy industry global market size, regional shares, competitors with the hormone replacement therapy market share, detailed hormone replacement therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the hormone replacement therapy industry. This hormone replacement therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hormone replacement therapy market size has grown strongly in recent years. It will grow from $25.06 billion in 2024 to $27.28 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth during the historic period can be attributed to the rising prevalence of menopausal symptoms among aging women, increased awareness of hormone deficiency treatments, longer life expectancy and an aging population, growing global healthcare spending, and the increasing use of estrogen therapy in postmenopausal women.

The hormone replacement therapy market size is expected to see strong growth in the next few years. It will grow to $37.90 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth during the forecast period can be attributed to the increasing prevalence of hormonal disorders, heightened awareness of menopausal health, a growing aging population globally, expanded healthcare access in emerging markets, and a rising demand for minimally invasive treatment options. Key trends in this period include progress in bio-identical hormone formulations, advanced transdermal drug delivery technologies, the development of personalized hormone therapies based on genetic profiling, innovations in long-acting hormone injectables, and advancements in telehealth integration for managing hormone therapy.

The growing number of postmenopausal women is expected to drive the expansion of the hormone replacement therapy market in the future. Postmenopausal women are those who have permanently ceased menstruation due to the natural reduction of reproductive hormones, usually occurring 12 months after their last period. This increase in postmenopausal women is linked to rising life expectancy, as women are living longer, leading to a larger aging female population undergoing menopause. Hormone replacement therapy benefits postmenopausal women by easing common symptoms like hot flashes and night sweats, thereby enhancing quality of life. It helps maintain hormonal balance through personalized treatments, reducing discomfort and supporting overall well-being. For example, in July 2022, Mayo Clinic Health System, a US-based healthcare organization, reported that the global population of menopausal and postmenopausal women is expected to reach 1.2 billion by 2030, with 47 million new cases annually. Consequently, the increasing number of postmenopausal women is fueling the growth of the hormone replacement therapy market.

Leading companies in the hormone replacement therapy market are concentrating on developing innovative formulations, including bio-identical hormone formulations, to enhance treatment effectiveness and patient adherence. Bio-identical hormone formulations utilize hormones that are chemically identical to those naturally produced by the human body, aiming to offer more natural and efficient symptom relief with fewer side effects. For example, in May 2024, Jagsonpal Pharmaceuticals Ltd., an India-based pharmaceutical firm, introduced MemUp, a bio-identical hormone replacement therapy (HRT). This advanced therapy combines estradiol and progesterone in a single, once-daily oral capsule. MemUp is designed to effectively relieve common menopausal symptoms such as hot flashes and night sweats while simplifying the treatment process to improve patient convenience and compliance.

In December 2024, Likarda, a US-based biotechnology firm, collaborated with VitalTE LifeSciences to develop extended-release injectable hormone therapies. This partnership seeks to improve patient convenience, increase treatment adherence, and provide a non-surgical alternative to conventional hormone delivery methods through innovative, long-acting formulations. VitalTE LifeSciences is a US-based biotechnology company focused on creating advanced hormone replacement therapy solutions.

Major players in the hormone replacement therapy market are Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Sanofi S.A., Abbott Laboratories, Novartis AG, GSK plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Cipla Inc., Gedeon Richter Plc., Lupin Limited, Orion Corporation, Halozyme Therapeutics Inc., Theramex HQ UK Limited.

North America was the largest region in the hormone replacement therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in hormone replacement therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hormone replacement therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hormone replacement therapy market includes revenues earned by entities through hormone level assessment, personalized treatment planning, prescription and administration of hormone therapies, patient monitoring, and follow-up care to manage symptoms related to hormonal imbalances. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hormone Replacement Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hormone replacement therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hormone replacement therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hormone replacement therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Therapy Type: Estrogen Replacement Therapy; Human Growth Hormone Replacement Therapy; Thyroid Hormone Replacement Therapy; Testosterone Replacement Therapy; Other Therapy Types
  • 2) By Indication: Menopause; Hypothyroidism; Male Hypogonadism; Growth Hormone Deficiency; Other Indications
  • 3) By Route Of Administration: Oral; Transdermal; Injectable; Other Of Administartions
  • 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
  • Subsegments:
  • 1) By Estrogen Replacement Therapy: Oral Estrogen; Transdermal Estrogen; Topical Estrogen; Vaginal Estrogen; Injectable Estrogen
  • 2) By Human Growth Hormone (hGH) Replacement Therap: Somatropin; Somatrem; Recombinant Human Growth Hormone (rhGH); Pegylated hGH; Other Human Growth Hormone (hGH) Replacement Therapies
  • 3) By Thyroid Hormone Replacement Therapy: Levothyroxine (T4); Liothyronine (T3); Natural Desiccated Thyroid (NDT); Combination T3 Or T4 Therapy
  • 4) By Testosterone Replacement Therapy: Gels And Creams; Injections; Patches; Oral Testosterone; Pellets
  • 5) By Other Therapy Types: Progesterone Replacement Therapy; Combined Estrogen-Progesterone Therapy; Dehydroepiandrosterone Therapy; Melatonin Replacement Therapy
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Bayer AG; Sanofi S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hormone Replacement Therapy Market Characteristics

3. Hormone Replacement Therapy Market Trends And Strategies

4. Hormone Replacement Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Hormone Replacement Therapy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Hormone Replacement Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Hormone Replacement Therapy Market Growth Rate Analysis
  • 5.4. Global Hormone Replacement Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Hormone Replacement Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Hormone Replacement Therapy Total Addressable Market (TAM)

6. Hormone Replacement Therapy Market Segmentation

  • 6.1. Global Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Estrogen Replacement Therapy
  • Human Growth Hormone Replacement Therapy
  • Thyroid Hormone Replacement Therapy
  • Testosterone Replacement Therapy
  • Other Therapy Types
  • 6.2. Global Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Other Indications
  • 6.3. Global Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Transdermal
  • Injectable
  • Other Of Administartions
  • 6.4. Global Hormone Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Other Distribution Channels
  • 6.5. Global Hormone Replacement Therapy Market, Sub-Segmentation Of Estrogen Replacement Therapy,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Estrogen
  • Transdermal Estrogen
  • Topical Estrogen
  • Vaginal Estrogen
  • Injectable Estrogen
  • 6.6. Global Hormone Replacement Therapy Market, Sub-Segmentation Of Human Growth Hormone (hGH) Replacement Therapy,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Somatropin
  • Somatrem
  • Recombinant Human Growth Hormone (rhGH)
  • Pegylated hGH
  • Other Human Growth Hormone (hGH) Replacement Therapies
  • 6.7. Global Hormone Replacement Therapy Market, Sub-Segmentation Of Thyroid Hormone Replacement Therapy,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Levothyroxine (T4)
  • Liothyronine (T3)
  • Natural Desiccated Thyroid (NDT)
  • Combination Liothyronine (T3) Or Levothyroxine (T4) Therapy
  • 6.8. Global Hormone Replacement Therapy Market, Sub-Segmentation Of Testosterone Replacement Therapy,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gels And Creams
  • Injections
  • Patches
  • Oral Testosterone
  • Pellets
  • 6.9. Global Hormone Replacement Therapy Market, Sub-Segmentation Of Other Therapy Types,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Progesterone Replacement Therapy
  • Combined Estrogen-Progesterone Therapy
  • Dehydroepiandrosterone Therapy
  • Melatonin Replacement Therapy

7. Hormone Replacement Therapy Market Regional And Country Analysis

  • 7.1. Global Hormone Replacement Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Hormone Replacement Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hormone Replacement Therapy Market

  • 8.1. Asia-Pacific Hormone Replacement Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hormone Replacement Therapy Market

  • 9.1. China Hormone Replacement Therapy Market Overview
  • 9.2. China Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hormone Replacement Therapy Market

  • 10.1. India Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hormone Replacement Therapy Market

  • 11.1. Japan Hormone Replacement Therapy Market Overview
  • 11.2. Japan Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hormone Replacement Therapy Market

  • 12.1. Australia Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hormone Replacement Therapy Market

  • 13.1. Indonesia Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hormone Replacement Therapy Market

  • 14.1. South Korea Hormone Replacement Therapy Market Overview
  • 14.2. South Korea Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hormone Replacement Therapy Market

  • 15.1. Western Europe Hormone Replacement Therapy Market Overview
  • 15.2. Western Europe Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hormone Replacement Therapy Market

  • 16.1. UK Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hormone Replacement Therapy Market

  • 17.1. Germany Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hormone Replacement Therapy Market

  • 18.1. France Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hormone Replacement Therapy Market

  • 19.1. Italy Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hormone Replacement Therapy Market

  • 20.1. Spain Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hormone Replacement Therapy Market

  • 21.1. Eastern Europe Hormone Replacement Therapy Market Overview
  • 21.2. Eastern Europe Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hormone Replacement Therapy Market

  • 22.1. Russia Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hormone Replacement Therapy Market

  • 23.1. North America Hormone Replacement Therapy Market Overview
  • 23.2. North America Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hormone Replacement Therapy Market

  • 24.1. USA Hormone Replacement Therapy Market Overview
  • 24.2. USA Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hormone Replacement Therapy Market

  • 25.1. Canada Hormone Replacement Therapy Market Overview
  • 25.2. Canada Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hormone Replacement Therapy Market

  • 26.1. South America Hormone Replacement Therapy Market Overview
  • 26.2. South America Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hormone Replacement Therapy Market

  • 27.1. Brazil Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hormone Replacement Therapy Market

  • 28.1. Middle East Hormone Replacement Therapy Market Overview
  • 28.2. Middle East Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hormone Replacement Therapy Market

  • 29.1. Africa Hormone Replacement Therapy Market Overview
  • 29.2. Africa Hormone Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Hormone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Hormone Replacement Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hormone Replacement Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Hormone Replacement Therapy Market Competitive Landscape
  • 30.2. Hormone Replacement Therapy Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Hormone Replacement Therapy Market Other Major And Innovative Companies

  • 31.1. Abbott Laboratories
  • 31.2. Novartis AG
  • 31.3. GSK plc
  • 31.4. Eli Lilly and Company
  • 31.5. Amgen Inc.
  • 31.6. Novo Nordisk A/S
  • 31.7. Teva Pharmaceutical Industries Ltd.
  • 31.8. Mylan N.V.
  • 31.9. Bausch Health Companies Inc.
  • 31.10. Cipla Inc.
  • 31.11. Gedeon Richter Plc.
  • 31.12. Lupin Limited
  • 31.13. Orion Corporation
  • 31.14. Halozyme Therapeutics Inc.
  • 31.15. Theramex HQ UK Limited

32. Global Hormone Replacement Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hormone Replacement Therapy Market

34. Recent Developments In The Hormone Replacement Therapy Market

35. Hormone Replacement Therapy Market High Potential Countries, Segments and Strategies

  • 35.1 Hormone Replacement Therapy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Hormone Replacement Therapy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Hormone Replacement Therapy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer